Pms-Metoclopramide en es it fr

Pms-Metoclopramide Brand names, Pms-Metoclopramide Analogs

Pms-Metoclopramide Brand Names Mixture

  • No information avaliable

Pms-Metoclopramide Chemical_Formula


Pms-Metoclopramide RX_link

Pms-Metoclopramide fda sheet

Pms-Metoclopramide FDA

Pms-Metoclopramide msds (material safety sheet)

Pms-Metoclopramide MSDS

Pms-Metoclopramide Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Pms-Metoclopramide Molecular Weight

299.796 g/mol

Pms-Metoclopramide Melting Point

147.25 oC

Pms-Metoclopramide H2O Solubility

200 mg/L

Pms-Metoclopramide State


Pms-Metoclopramide LogP


Pms-Metoclopramide Dosage Forms

Liquid; Syrup; Tablet

Pms-Metoclopramide Indication

For the treatment of gastroesophageal reflux disease (GERD)

Pms-Metoclopramide Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Pms-Metoclopramide Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Pms-Metoclopramide side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Pms-Metoclopramide Patient Information

Pms-Metoclopramide Organisms Affected

Humans and other mammals